Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human intranasal outer membrane vesicle-based pneumococcal vaccine trial
NL-OMON61805Phase 1Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1 trial of Ab-01.12 in pneumococcal disease, sponsored by Radboud University Medical Center. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
Ab-01.12
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NL-OMON61805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61805.